Osmotica Pharmaceutical recalls

Osmotica Pharmaceutical has 4 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 14 Mar 2018. The most frequent reason is potency & assay.

Total recalls4since 2013

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Mar 2018

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 4 100%

Why osmotica pharmaceutical is recalled

Potency & Assay4100%

Product types

ADHD Medication375%
Antidepressants125%

By year

2018125%
2017250%
2013125%

All osmotica pharmaceutical recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
14 Mar 2018Drug	CLASS III	Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg recalledMethylphenidate Hydrochloride	Osmotica Pharmaceutical	Potency & Assay	Nationwide
27 Dec 2017Drug	CLASS III	Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg recalledMethylphenidate Hydrochloride	Osmotica Pharmaceutical	Potency & Assay	Nationwide
27 Dec 2017Drug	CLASS III	Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg recalledMethylphenidate Hydrochloride	Osmotica Pharmaceutical	Potency & Assay	Nationwide
9 Oct 2013Drug	CLASS III	Venlafaxine (Venlafaxine Hydrochloride) extended release recalled	Osmotica Pharmaceutical	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.